Stay updated on Pegcetacoplan in TA-TMA post-HSCT Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in TA-TMA post-HSCT Clinical Trial page.

Latest updates to the Pegcetacoplan in TA-TMA post-HSCT Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check12 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check49 days agoChange DetectedThe web page has been updated to reflect a new version of the study protocol for pegcetacoplan in patients with Transplant-Associated Thrombotic Microangiopathy (TA-TMA), with significant details about the study's purpose and patient criteria removed.SummaryDifference26%
- Check56 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to December 19, 2024.SummaryDifference0.6%
- Check64 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Pegcetacoplan in TA-TMA post-HSCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in TA-TMA post-HSCT Clinical Trial page.